Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Nabity, Scott A. ; Marks, Suzanne M. ; Goswami, Neela D. ; Smith, Shona R. ; Timme, Evan ; Price, Sandy F. ; Gross, Lon ; Self, Julie L. ; Toren, Katelynne Gardner ; Narita, Masahiro ; Wegener, Donna H. ; Wang, Shu-Hua
• Corporate Authors:
  for the National Tuberculosis Controllers Association/CDC TB-COVID-19 Collaboration1
• Description:
  Little is known about co-occurring tuberculosis (TB) and COVID-19 in low TB incidence settings. We obtained a cross-section of 333 persons in the United States co-diagnosed with TB and COVID-19 within 180 days and compared them to 4,433 persons with TB only in 2020 and 18,898 persons with TB during 2017‒2019. Across both comparison groups, a higher proportion of persons with TB-COVID-19 were Hispanic, were long-term care facility residents, and had diabetes. When adjusted for age, underlying conditions, and TB severity, COVID-19 co-infection was not statistically associated with death compared with TB infection only in 2020 (adjusted prevalence ratio 1.0 [95% CI 0.8‒1.4]). Among TB-COVID-19 patients, death was associated with a shorter interval between TB and COVID-19 diagnoses, older age, and being immunocompromised (non-HIV). TB-COVID-19 deaths in the United States appear to be concentrated in subgroups sharing characteristics known to increase risk for death from either disease alone.
• Subjects:
  Characteristics Of And Deaths Among 333 Persons With Tuberculosis And COVID-19 In Cross-Sectional Sample From 25 Jurisdictions, United States Research
• Keywords:
  Bacteria Bacterial Infection Coronavirus Disease COVID-19 Cross-Sectional Studies Humans Respiratory Infections SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 Tuberculosis Tuberculosis And Other Mycobacteria United States Vaccine-preventable Diseases Viruses Zoonoses

  More +
• Source:
  Emerg Infect Dis. 2023; 29(10):2016-2023
• Pubmed ID:
  37647628
• Pubmed Central ID:
  PMC10521611
• Document Type:
  Journal Article
• Volume:
  29
• Issue:
  10
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:1ce2788599c43ab041f580944f4446482b9959a6939b0f0581cb9017029e3a46
• Download URL:
  https://stacks.cdc.gov/view/cdc/134746/cdc_134746_DS1.pdf
• File Type:
  [PDF - 725.85 KB ]